Country/Region

This publication seeks to remedy some of the existing knowledge gaps by raising awareness on existing price differentials, exploring what factors drive fluctuations in vaccine prices and discussing where development of better-adapted vaccines could reduce barriers to immunization and increase coverage levels of traditional and newer vaccines. 

As the crisis in Syria intensifies daily, with thousands continuing to flee to neighboring countries to search for safety, humanitarian needs inside and outside the country are escalating rapidly. 

While gains made in the fight against HIV/AIDS in the past decade are encouraging, countries most affected by the pandemic continue to struggle to place enough people on treatment and implement the best science and strategies to fight the disease.

"Fighting Neglect" charts MSF's 25 years of experience in diagnosing and treating Chagas disease, sleeping sickness, and kala azar in Latin America, Sub-Saharan Africa, South Asia, and the Caucasus.

This six-month progress report reviews the steps taken to achieve the Action Plan agreed by delegates at the International Conference on Lead Poisoning. It finds that on nearly all agreed action points, very little has materialized.

Operational research from MSF projects in Burundi and Sierra Leone indicate that it is possible to achieve a rapid and substantial decrease in maternal deaths of up to 74 percent by providing access to emergency obstetric care.

Violence against civilians is devastating communities and preventing access to lifesaving health care in Jonglei.

Encompassing eleven countries and slated for further expansion across the Asia Pacific region, the Trans-Pacific Partnership Agreement (TPP) is a regional trade agreement that will set the standard for 21st-century trade agreements going forward.

This report focuses on just some of the many factors that hamper the scaling up of DR-TB treatment—the limited availability and high cost of quality assured medicines for resistant strains of the disease, owing to an insecure market and insufficient demand; and the research questions that remain unsolved with existing medicines.

This report specifically focuses on MSF’s work with Syrian refugees and other displaced populations in Lebanon, where MSF teams are providing urgent assistance and free-of-charge medical care among people now sheltering in Tripoli and in various locations of the Bekaa Valley.

Pages